<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Dr Bruno Santos Archive - SpaceWatch.GLOBAL</title>
	<atom:link href="https://spacewatch.global/tag/dr-bruno-santos/feed/" rel="self" type="application/rss+xml" />
	<link>https://spacewatch.global/tag/dr-bruno-santos/</link>
	<description>AN INDEPENDENT PERSPECTIVE ON SPACE</description>
	<lastBuildDate>Tue, 10 Feb 2026 06:20:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://spacewatch.global/wp-content/uploads/2024/09/SpaceWatchGlobal-Sign-90x90.png</url>
	<title>Dr Bruno Santos Archive - SpaceWatch.GLOBAL</title>
	<link>https://spacewatch.global/tag/dr-bruno-santos/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Exobiosphere, Myriamed, and KIST-Europe&#8217;s &#8216;MyrSpaceCardio&#8217; to Advance Cardiac Tissue Engineering in Space</title>
		<link>https://spacewatch.global/2026/02/exobiosphere-myriamed-and-kist-europes-myrspacecardio-to-advance-cardiac-tissue-engineering-in-space/</link>
		
		<dc:creator><![CDATA[Joshua Faleti]]></dc:creator>
		<pubDate>Tue, 10 Feb 2026 07:00:00 +0000</pubDate>
				<category><![CDATA[Frontiers News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Dr Bruno Santos]]></category>
		<category><![CDATA[European Space Agency Business in Space Growth Network (BSGN) Life Science Industry Accelerator]]></category>
		<category><![CDATA[Exobiosphere]]></category>
		<category><![CDATA[KIST-Europe Forschungsgesellschaft mbH]]></category>
		<category><![CDATA[Myriamed GmbH]]></category>
		<category><![CDATA[Prof. Dr. Wolfram-Hubertus Zimmermann]]></category>
		<guid isPermaLink="false">https://spacewatch.global/?p=71083</guid>

					<description><![CDATA[<a href="https://spacewatch.global/2026/02/exobiosphere-myriamed-and-kist-europes-myrspacecardio-to-advance-cardiac-tissue-engineering-in-space/" title="Exobiosphere, Myriamed, and KIST-Europe&#8217;s &#8216;MyrSpaceCardio&#8217; to Advance Cardiac Tissue Engineering in Space" rel="nofollow"><img width="800" height="400" src="https://spacewatch.global/wp-content/uploads/2026/02/Myriamed-KIST-Europe-and-Exobiosphere-Selected-for-ESA-BSGN-Accelerator-to-Advance-Cardiac-Tissue-Engineering-in-Space-800x400.webp" class="webfeedsFeaturedVisual wp-post-image" alt="Exobiosphere, Myriamed, and KIST-Europe Selected to Advance Cardiac Tissue Engineering in Space" style="display: block; margin-bottom: 5px; clear:both;max-width: 100%;" link_thumbnail="1" decoding="async" srcset="https://spacewatch.global/wp-content/uploads/2026/02/Myriamed-KIST-Europe-and-Exobiosphere-Selected-for-ESA-BSGN-Accelerator-to-Advance-Cardiac-Tissue-Engineering-in-Space-800x400.webp 800w, https://spacewatch.global/wp-content/uploads/2026/02/Myriamed-KIST-Europe-and-Exobiosphere-Selected-for-ESA-BSGN-Accelerator-to-Advance-Cardiac-Tissue-Engineering-in-Space-360x180.webp 360w" sizes="(max-width: 800px) 100vw, 800px" /></a>Myriamed GmbH, KIST-Europe Forschungsgesellschaft mbH, and Exobiosphere have been selected for the European Space Agency Business in Space Growth Network (BSGN) Life Science Industry Accelerator with their joint project 'myrSpaceCardio’, a pioneering initiative to develop next-generation human cardiac tissue models in microgravity. The project addresses a major bottleneck in drug development and cardiac disease research.]]></description>
		
		
		
			</item>
	</channel>
</rss>
